期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Engineering nanotheranostic strategies for liver cancer
1
作者 Lei Cao yu-qin zhu +2 位作者 Zhi-Xian Wu Gao-Xiong Wang Hong-Wei Cheng 《World Journal of Gastrointestinal Oncology》 SCIE 2021年第10期1213-1228,共16页
The incidence and mortality of hepatocellular carcinoma have continued to increase over the last few years,and the medicine-based outlook of patients is poor.Given great ideas from the development of nanotechnology in... The incidence and mortality of hepatocellular carcinoma have continued to increase over the last few years,and the medicine-based outlook of patients is poor.Given great ideas from the development of nanotechnology in medicine,especially the advantages in the treatments of liver cancer.Some engineering nanoparticles with active targeting,ligand modification,and passive targeting capacity achieve efficient drug delivery to tumor cells.In addition,the behavior of drug release is also applied to the drug loading nanosystem based on the tumor microenvironment.Considering clinical use of local treatment of liver cancer,in situ drug delivery of nanogels is also fully studied in orthotopic chemotherapy,radiotherapy,and ablation therapy.Furthermore,novel therapies including gene therapy,phototherapy,and immunotherapy are also applied as combined therapy for liver cancer.Engineering nonviral polymers to function as gene delivery vectors with increased efficiency and specificity,and strategies of co-delivery of therapeutic genes and drugs show great therapeutic effect against liver tumors,including drug-resistant tumors.Phototherapy is also applied in surgical procedures,chemotherapy,and immunotherapy.Combination strategies significantly enhance therapeutic effects and decrease side effects.Overall,the application of nanotechnology could bring a revolutionary change to the current treatment of liver cancer. 展开更多
关键词 Liver cancer Poor prognosis Nanotheranostic Drug delivery Gene delivery Combination therapy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部